Antidiabetic Medications and the Risk of Endometrial Cancer in Patients
Conclusion: Our data indicate that metformin, SUs, and insulin did not meaningfully affect the risk of EC. Further investigation is warranted.Gynecol Obstet Invest
Source: Gynecologic and Obstetric Investigation - Category: OBGYN Source Type: research
More News: Cancer | Cancer & Oncology | Databases & Libraries | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Endometrial Cancer | Epidemiology | Fortamet | Insulin | Metformin | OBGYN | Study